Identification of revertants for the cystic fibrosis ΔF508 mutation using STE6-CFTR chimeras in yeast

159Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) cause cystic fibrosis; the most common mutation is deletion of phenylalanine at position 508 (ΔF508). We constructed STE6-CFTR chimeras with portions of the first nucleotide-binding domain (NBD1) of the yeast STE6 a-factor transporter replaced by portions of CFTR NBD1. The chimeras were functional in yeast, but mating efficiency decreased when ΔF508 was introduced into NBD1. We isolated two ΔF508 revertant mutations (R553M and R553Q) that restored mating; both were located within the CFTR NBD1 sequence. Introduction of these revertant mutations into human CFTR partially corrected the processing and CI- channel gating defects caused by the ΔF508 mutation. These results suggest that the NBD1s of CFTR and STE6 share a similar structure and function and that, in CFTR, the regions containing F508 and R553 interact. They also indicate that the abnormal conformation produced by ΔF508 can be partially corrected by additional alterations in the protein. © 1993.

Cite

CITATION STYLE

APA

Teem, J. L., Berger, H. A., Ostedgaard, L. S., Rich, D. P., Tsui, L. C., & Welsh, M. J. (1993). Identification of revertants for the cystic fibrosis ΔF508 mutation using STE6-CFTR chimeras in yeast. Cell, 73(2), 335–346. https://doi.org/10.1016/0092-8674(93)90233-G

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free